Martha Steele’s life changed suddenly in December 2017, when she was injured in a car accident. The result was a painful nerve compression injury that sidelined the Air Force veteran, full-time hospital worker, and grandmother of three.
The safety and quality of allograft bio-implants are critical to physicians and their patients. As a leading regenerative medicine company, LifeNet Health has developed a full suite of technologies to ensure these needs are met with every bio-implant we provide.
LifeNet Health offers four allograft bio-implant technologies every surgeon should take note of:
ViviGen can be used in a variety of procedures and in the most challenging patients to provide successful clinical outcomes.
The most recent peer-reviewed paper published in Cell and Tissue Banking outlines a comprehensive series of in vitro and in vivo assays demonstrating that LifeNet Health’s viable bone allograft, ViviGen, provides all three essential bone remodeling properties and contains viable, lineage-committed bone-forming cells that do not elicit an immune response. Together, the results support ViviGen as a safe and effective alternative to autograft, without the associated drawbacks.
SymAlign Evans and Cotton Osteotomy wedges are intended for use in foot procedures. The wedges are sourced from cancellous bone from the femoral heads and condyles, talus and calcaneus, which have been determined to have appropriate strength for these procedures.1 This, along with specific donor- and graft-selection criteria, ensures the high density and optimized strength necessary to maintain the deformity correction during impaction as well as throughout the healing/incorporation process.